Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate Cancer.

Haddad BR, Erickson A, Udhane V, LaViolette PS, Rone JD, Kallajoki MA, See WA, Rannikko A, Mirtti T, Nevalainen MT.

Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1642-1651. doi: 10.1158/1055-9965.EPI-18-1358. Epub 2019 Jul 10.

PMID:
31292140
2.

An integrated iterative annotation technique for easing neural network training in medical image analysis.

Lutnick B, Ginley B, Govind D, McGarry SD, LaViolette PS, Yacoub R, Jain S, Tomaszewski JE, Jen KY, Sarder P.

Nat Mach Intell. 2019 Feb;1(2):112-119. doi: 10.1038/s42256-019-0018-3. Epub 2019 Feb 11.

PMID:
31187088
3.

Gleason Probability Maps: A Radiomics Tool for Mapping Prostate Cancer Likelihood in MRI Space.

McGarry SD, Bukowy JD, Iczkowski KA, Unteriner JG, Duvnjak P, Lowman AK, Jacobsohn K, Hohenwalter M, Griffin MO, Barrington AW, Foss HE, Keuter T, Hurrell SL, See WA, Nevalainen MT, Banerjee A, LaViolette PS.

Tomography. 2019 Mar;5(1):127-134. doi: 10.18383/j.tom.2018.00033.

4.

The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II.

Huang W, Chen Y, Fedorov A, Li X, Jajamovich GH, Malyarenko DI, Aryal MP, LaViolette PS, Oborski MJ, O'Sullivan F, Abramson RG, Jafari-Khouzani K, Afzal A, Tudorica A, Moloney B, Gupta SN, Besa C, Kalpathy-Cramer J, Mountz JM, Laymon CM, Muzi M, Kinahan PE, Schmainda K, Cao Y, Chenevert TL, Taouli B, Yankeelov TE, Fennessy F, Li X.

Tomography. 2019 Mar;5(1):99-109. doi: 10.18383/j.tom.2018.00027.

5.

Vascular Interventional Radiology-Guided Photothermal Therapy of Colorectal Cancer Liver Metastasis with Theranostic Gold Nanorods.

Parchur AK, Sharma G, Jagtap JM, Gogineni VR, LaViolette PS, Flister MJ, White SB, Joshi A.

ACS Nano. 2018 Jul 24;12(7):6597-6611. doi: 10.1021/acsnano.8b01424. Epub 2018 Jul 6.

PMID:
29969226
6.

Radio-pathomic Maps of Epithelium and Lumen Density Predict the Location of High-Grade Prostate Cancer.

McGarry SD, Hurrell SL, Iczkowski KA, Hall W, Kaczmarowski AL, Banerjee A, Keuter T, Jacobsohn K, Bukowy JD, Nevalainen MT, Hohenwalter MD, See WA, LaViolette PS.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1179-1187. doi: 10.1016/j.ijrobp.2018.04.044. Epub 2018 Apr 24.

7.

Split laminotomy versus conventional laminotomy: postoperative outcomes in pediatric patients.

Arocho-Quinones EV, Kolimas A, LaViolette PS, Kaufman BA, Foy AB, Zwienenberg M, Lew SM.

J Neurosurg Pediatr. 2018 Jun;21(6):615-625. doi: 10.3171/2017.12.PEDS17368. Epub 2018 Mar 23.

PMID:
29570034
8.

Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging.

Hurrell SL, McGarry SD, Kaczmarowski A, Iczkowski KA, Jacobsohn K, Hohenwalter MD, Hall WA, See WA, Banerjee A, Charles DK, Nevalainen MT, Mackinnon AC, LaViolette PS.

J Med Imaging (Bellingham). 2018 Jan;5(1):011004. doi: 10.1117/1.JMI.5.1.011004. Epub 2017 Oct 27.

9.

Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer.

Flister MJ, Tsaih SW, Stoddard A, Plasterer C, Jagtap J, Parchur AK, Sharma G, Prisco AR, Lemke A, Murphy D, Al-Gizawiy M, Straza M, Ran S, Geurts AM, Dwinell MR, Greene AS, Bergom C, LaViolette PS, Joshi A.

Breast Cancer Res Treat. 2017 Aug;165(1):53-64. doi: 10.1007/s10549-017-4311-8. Epub 2017 May 31.

10.

Magnetic Resonance Imaging-Based Radiomic Profiles Predict Patient Prognosis in Newly Diagnosed Glioblastoma Before Therapy.

McGarry SD, Hurrell SL, Kaczmarowski AL, Cochran EJ, Connelly J, Rand SD, Schmainda KM, LaViolette PS.

Tomography. 2016 Sep;2(3):223-228.

11.

Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma.

Nguyen HS, Milbach N, Hurrell SL, Cochran E, Connelly J, Bovi JA, Schultz CJ, Mueller WM, Rand SD, Schmainda KM, LaViolette PS.

AJNR Am J Neuroradiol. 2016 Dec;37(12):2201-2208. Epub 2016 Aug 4.

12.

The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge.

Huang W, Chen Y, Fedorov A, Li X, Jajamovich GH, Malyarenko DI, Aryal MP, LaViolette PS, Oborski MJ, O'Sullivan F, Abramson RG, Jafari-Khouzani K, Afzal A, Tudorica A, Moloney B, Gupta SN, Besa C, Kalpathy-Cramer J, Mountz JM, Laymon CM, Muzi M, Schmainda K, Cao Y, Chenevert TL, Taouli B, Yankeelov TE, Fennessy F, Li X.

Tomography. 2016 Mar;2(1):56-66.

13.

Location of brain tumor intersecting white matter tracts predicts patient prognosis.

Mickevicius NJ, Carle AB, Bluemel T, Santarriaga S, Schloemer F, Shumate D, Connelly J, Schmainda KM, LaViolette PS.

J Neurooncol. 2015 Nov;125(2):393-400. doi: 10.1007/s11060-015-1928-5. Epub 2015 Sep 16.

14.

Photodynamic therapy (PDT) for malignant brain tumors--where do we stand?

Quirk BJ, Brandal G, Donlon S, Vera JC, Mang TS, Foy AB, Lew SM, Girotti AW, Jogal S, LaViolette PS, Connelly JM, Whelan HT.

Photodiagnosis Photodyn Ther. 2015 Sep;12(3):530-44. doi: 10.1016/j.pdpdt.2015.04.009. Epub 2015 May 8. Review.

15.

Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme.

Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS.

J Neurooncol. 2015 May;123(1):179-88. doi: 10.1007/s11060-015-1782-5. Epub 2015 Apr 17.

PMID:
25894597
16.

CXM: a new tool for mapping breast cancer risk in the tumor microenvironment.

Flister MJ, Endres BT, Rudemiller N, Sarkis AB, Santarriaga S, Roy I, Lemke A, Geurts AM, Moreno C, Ran S, Tsaih SW, De Pons J, Carlson DF, Tan W, Fahrenkrug SC, Lazarova Z, Lazar J, North PE, LaViolette PS, Dwinell MB, Shull JD, Jacob HJ.

Cancer Res. 2014 Nov 15;74(22):6419-29. doi: 10.1158/0008-5472.CAN-13-3212. Epub 2014 Aug 29.

17.

Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma.

LaViolette PS, Mickevicius NJ, Cochran EJ, Rand SD, Connelly J, Bovi JA, Malkin MG, Mueller WM, Schmainda KM.

Neuro Oncol. 2014 Dec;16(12):1599-606. doi: 10.1093/neuonc/nou142. Epub 2014 Jul 24.

18.

Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics.

Heroux MS, Chesnik MA, Halligan BD, Al-Gizawiy M, Connelly JM, Mueller WM, Rand SD, Cochran EJ, LaViolette PS, Malkin MG, Schmainda KM, Mirza SP.

Physiol Genomics. 2014 Jul 1;46(13):467-81. doi: 10.1152/physiolgenomics.00034.2014. Epub 2014 May 6.

19.

Fibrin sealant to prevent subdural electrode migration during intracranial electroencephalographic monitoring in a patient with a large arachnoid cyst.

Hoyt AT, LaViolette PS, Lew SM.

J Neurosurg Pediatr. 2014 Jul;14(1):115-9. doi: 10.3171/2014.3.PEDS13489. Epub 2014 May 2.

PMID:
24784977
20.

Effect of contrast leakage on the detection of abnormal brain tumor vasculature in high-grade glioma.

LaViolette PS, Daun MK, Paulson ES, Schmainda KM.

J Neurooncol. 2014 Feb;116(3):543-549. doi: 10.1007/s11060-013-1318-9. Epub 2013 Nov 29.

21.

The role of pre-treatment white matter abnormalities in developing white matter changes following whole brain radiation: a volumetric study.

Sabsevitz DS, Bovi JA, Leo PD, Laviolette PS, Rand SD, Mueller WM, Schultz CJ.

J Neurooncol. 2013 Sep;114(3):291-7. doi: 10.1007/s11060-013-1181-8. Epub 2013 Jun 30.

PMID:
23813291
22.

Effects of perfusion on diffusion changes in human brain tumors.

Cohen AD, LaViolette PS, Prah M, Connelly J, Malkin MG, Rand SD, Mueller WM, Schmainda KM.

J Magn Reson Imaging. 2013 Oct;38(4):868-75. doi: 10.1002/jmri.24042. Epub 2013 Feb 6.

23.

Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma.

LaViolette PS, Cohen AD, Prah MA, Rand SD, Connelly J, Malkin MG, Mueller WM, Schmainda KM.

Neuro Oncol. 2013 Apr;15(4):442-50. doi: 10.1093/neuonc/nos323. Epub 2013 Feb 3.

24.

Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials.

Atri A, O'Brien JL, Sreenivasan A, Rastegar S, Salisbury S, DeLuca AN, O'Keefe KM, LaViolette PS, Rentz DM, Locascio JJ, Sperling RA.

Arch Neurol. 2011 May;68(5):599-606. doi: 10.1001/archneurol.2011.94.

25.

Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRI.

Ellingson BM, LaViolette PS, Rand SD, Malkin MG, Connelly JM, Mueller WM, Prost RW, Schmainda KM.

Magn Reson Med. 2011 Apr;65(4):1131-43. doi: 10.1002/mrm.22688. Epub 2010 Nov 30.

26.

3D visualization of subdural electrode shift as measured at craniotomy reopening.

LaViolette PS, Rand SD, Ellingson BM, Raghavan M, Lew SM, Schmainda KM, Mueller W.

Epilepsy Res. 2011 Mar;94(1-2):102-9. doi: 10.1016/j.eplepsyres.2011.01.011. Epub 2011 Feb 18.

27.

Three-dimensional visualization of subdural electrodes for presurgical planning.

LaViolette PS, Rand SD, Raghavan M, Ellingson BM, Schmainda KM, Mueller W.

Neurosurgery. 2011 Mar;68(1 Suppl Operative):152-60; discussion 160-1. doi: 10.1227/NEU.0b013e31820783ba.

28.

Imaging the functional connectivity of the Periaqueductal Gray during genuine and sham electroacupuncture treatment.

Zyloney CE, Jensen K, Polich G, Loiotile RE, Cheetham A, LaViolette PS, Tu P, Kaptchuk TJ, Gollub RL, Kong J.

Mol Pain. 2010 Nov 16;6:80. doi: 10.1186/1744-8069-6-80.

29.

Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas.

Ellingson BM, Malkin MG, Rand SD, LaViolette PS, Connelly JM, Mueller WM, Schmainda KM.

J Neurooncol. 2011 Mar;102(1):95-103. doi: 10.1007/s11060-010-0293-7. Epub 2010 Aug 27.

30.

Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline.

O'Brien JL, O'Keefe KM, LaViolette PS, DeLuca AN, Blacker D, Dickerson BC, Sperling RA.

Neurology. 2010 Jun 15;74(24):1969-76. doi: 10.1212/WNL.0b013e3181e3966e. Epub 2010 May 12.

31.

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity.

Ellingson BM, Malkin MG, Rand SD, Connelly JM, Quinsey C, LaViolette PS, Bedekar DP, Schmainda KM.

J Magn Reson Imaging. 2010 Mar;31(3):538-48. doi: 10.1002/jmri.22068.

32.

Functional alterations in memory networks in early Alzheimer's disease.

Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, Vitolo OV, Hedden T, Becker JA, Rentz DM, Selkoe DJ, Johnson KA.

Neuromolecular Med. 2010 Mar;12(1):27-43. doi: 10.1007/s12017-009-8109-7. Review.

33.

Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder.

Brown AB, Biederman J, Valera EM, Doyle AE, Bush G, Spencer T, Monuteaux MC, Mick E, Whitfield-Gabrieli S, Makris N, LaViolette PS, Oscar-Berman M, Faraone SV, Seidman LJ.

Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):365-375. doi: 10.1002/ajmg.b.31022.

34.

Amyloid deposition is associated with impaired default network function in older persons without dementia.

Sperling RA, Laviolette PS, O'Keefe K, O'Brien J, Rentz DM, Pihlajamaki M, Marshall G, Hyman BT, Selkoe DJ, Hedden T, Buckner RL, Becker JA, Johnson KA.

Neuron. 2009 Jul 30;63(2):178-88. doi: 10.1016/j.neuron.2009.07.003.

Supplemental Content

Loading ...
Support Center